1,624.00
-6.00
(-0.37%)
Real-time:
8:39am BST
LON real-time data - Disclaimer
Currency in GBX unless noted
| Range | 1,618.24 - 1,636.90 |
| 52 week | 1,094.00 - 1,777.65 |
| Open | 1,635.00 |
| Vol / Avg. | 699.00/33.00 |
| Mkt cap | 913.02M* |
| P/E | 33.20 |
| Div/yield | 3.05/0.63* |
| EPS | 0.49* |
| Shares | 56.22M |
| Beta | - |
| Inst. own | - |
| *GBP |
Events
Jun 11, 2013
Preliminary 2012 Oxford Instruments PLC Earnings Release
|
|
Key stats and ratios
| Q3 (Sep '12) | 2012 | |
| Net profit margin | 6.85% | 7.35% |
| Operating margin | 10.30% | 10.29% |
| EBITD margin | - | 15.54% |
| Return on average assets | 8.15% | 10.06% |
| Return on average equity | 18.40% | 22.48% |
| Employees | 1,834 | - |
| Carbon Disclosure Rating | - | - |
Address
Oxon, Tubney Woods
ABINGDON, ENG OX13 5QX
United Kingdom - Map
+44-1865-393200 (Phone)
+44-1865-393442 (Fax)
ABINGDON, ENG OX13 5QX
United Kingdom - Map
+44-1865-393200 (Phone)
+44-1865-393442 (Fax)
Website links
External links
Analyst Estimates - BusinessWeek
Options - MarketWatch
Research Reports - Reuters
Director Dealings - Yahoo Finance
Discussion Group - Google Finance
Advertisement
Description
Oxford Instruments plc is a holding company. The Company is engaged in the research, development, manufacture and sale of high technology tools and systems. The Company operates in three segments: Nanotechnology Tools, Industrial Products and Service segment. The Nanotechnology Tools segment contains a range of businesses supplying similar products, characterized by a high degree of customization and high unit prices. Its nanotechnology tools include NanoAnalysis, NanoScience, Plasma Technology and Omicron NanoTechnology. The Industrial Products segment contains a range of businesses supplying high technology products and components manufactured in medium volume for industrial customers. The Service segment contains the Company�s service business, as well as service revenues from other parts of the Company. On June 13, 2011, the Company acquired Omicron NanoTechnology GmbH and Omniprobe, Inc. On November 3, 2011, the Company acquired Platinum Medical Imaging LLC.
Officers and directors
| D. Jonathan Flint CBE., | Chief Executive, Executive Director | |
| Kevin J. Boyd | Group Finance Director, Executive Director | |
| Charles J.A. Holroyd | Group Business Development Director, Executive Director | |
| Susan Johnson-Brett | Company Secretary | |
| Nigel J. Keen | Independent Non-Executive Chairman of the Board | |
| J. Michael Brady | Non-Executive Deputy Chairman of the Board | |
| Thomas Geitner | Independent Non-Executive Director | |
| Michael Alan Hughes OBE | Senior Independent Non-Executive Director | |
| Jock Fyfe Lennox | Independent Non-Executive Director |